![]() T reatment of Acute Neurological Complications…e513 Deep Vein Thrombosis and Pulmonary Embolism…e512 A dmission to the Hospital and General Acute Treatment (After Hospitalization)…e510Ĭ. Thrombolysis and Antiplatelet Agents…e508 Combination of Thrombolysis and Neuroprotective Therapies…e508ī. C ombination Reperfusion Therapy in Acute Stroke…e507Ī. Induced Hypertension for the Management of Acute Ischemic Stroke…e505 Vasodilators in Acute Ischemic Stroke…e505Ĭ. Hemodilution in Acute Ischemic Stroke…e504ī. V olume Expansion, Vasodilators, and Induced Hypertension…e504Ī. Combination of Oral Antiplatelet Agents…e503 Anticoagulants as an Adjunctive Therapy…e502ī. Low-Molecular-Weight Heparins and Danaparoid…e502Ĭ. Recombinant Tissue Plasminogen Activator…e497ī. Airway, Ventilatory Support, and Supplemental Oxygen…e492Ī. G eneral Supportive Care and Treatment of Acute Complications…e492Ī. Non–Contrast-Enhanced CT Scan of the Brain…e489 E arly Diagnosis: Brain and Vascular Imaging…e489ġ. ![]() Neurological Examination and Stroke Scale Scores…e487 E mergency Evaluation and Diagnosis of Acute Ischemic Stroke…e486 P rehospital Management and Field Treatment…e480 ![]() Because many of the recommendations are based on limited data, additional research on treatment of acute ischemic stroke is needed. Several interventions, including intra-arterial administration of thrombolytic agents and mechanical interventions, show promise. Diggz xenon adults only password 2018 Activator#Intravenous administration of recombinant tissue plasminogen activator remains the most beneficial proven intervention for emergency treatment of stroke. This statement includes recommendations for management from the first contact by emergency medical services personnel through initial admission to the hospital. Results- Management of patients with acute ischemic stroke remains multifaceted and includes several aspects of care that have not been tested in clinical trials. It is intended that this guideline be fully updated in 3 years. ![]() After approval of the statement by the panel, it underwent peer review and approval by the American Heart Association Science Advisory and Coordinating Committee. The panel reviewed the relevant literature with an emphasis on reports published since 2003 and used the American Heart Association Stroke Council’s Levels of Evidence grading algorithm to rate the evidence and to make recommendations. Methods- Members of the panel were appointed by the American Heart Association Stroke Council’s Scientific Statement Oversight Committee and represented different areas of expertise. In addition, information for healthcare policy makers is included. The intended audience is physicians and other emergency healthcare providers who treat patients within the first 48 hours after stroke. ![]() Purpose- Our goal is to provide an overview of the current evidence about components of the evaluation and treatment of adults with acute ischemic stroke.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |